The University of Georgia Cancer Center was established
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…
-
-
OMRF opened the state’s first small animal magnetic resonance imaging facility
In 2004, the Oklahoma Medical Research Foundation (OMRF) opened the state’s first small animal magnetic resonance imaging facility….
-
The National Center for Research Resources awarded a $67 million grant to UGA for a Parkinson’s disease study
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
-
Results from the Prostate Cancer Prevention Trial showed men taking finasteride had 25 percent fewer diagnoses of prostate cancer than men taking placebo
On Jul. 17, 2003, the results from the Prostate Cancer Prevention Trial (PCPT) were published in New England…
-
Cancer Control PLANET, a web portal providing access to regularly updated cancer surveillance data, was launched
On Apr. 24, 2003, the National Cancer Institute, CDC, AHRQ, and SAMHSA, in collaboration with the American Cancer…
-
Winship Cancer Institute opened a new, 280,000-square-foot, state-of-the-art facility
In Sept. 2003, Emory’s Winship Cancer Institute opened a new, 280,000-square-foot, state-of-the-art facility, adding new research and high-tech…
-
Taking daily aspirin for as little as 3 years was shown to reduce the development of colorectal polyps
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
-
China granted the world’s first regulatory approval of a gene therapy product
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
-
Institute for Research in Immunology and Cancer created at the University of Montreal to discover more effective cancer therapies
In 2003, the Institute for Research in Immunology and Cancer (IRIC) was created at the University of Montreal…
-
Sidney Kimmel gave $150 million to Hopkins for cancer research and patient
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
-
NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune response
On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…
-
International consortium launched genetic variation mapping project
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…
-
NCI and FDA scientists reported patterns of proteins found in patients’ blood can distinguish between prostate cancer and benign conditions
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
-
National Cancer Institute researchers replace a patient’s immune system with cancer-fighting cells
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
-
NCI funded trial showed postmenopausal women who used estrogen replacement therapy were at higher risk of developing ovarian cancer
On Jul. 17, 2002, a National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
-
Biotechnology | Diagnostics | Disease | Life Science History | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
-
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
-
Andrew C von Eschenbach became the twelfth director of the National Cancer Institute, serving until 2006
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
-
Biotechnology | Genomics | HIV | Oncology
Stanford researchers became the first to use RNAi to switch off genes in mice
In 2002, Stanford geneticist Mark Kay uses a gene-therapy technique known as RNA inhibition to switch off genes…
-
Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
-
Digital diagnostic technology developed with creation of AQUA (Automated Quantitative Analysis) at Yale Cancer Center
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
-
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
-
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
The Cancer Center at Baylor College of Medicine was established
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
-
Researchers discovered the E6 and E7 gene in HPV
On Nov. 28, 2001, researchers discovered the E6 and E7 gene in HPV virus, linking cervical cancer cell…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The National Cancer Institute launched the Consumer Advocates in Research and Related Activities program
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
-
The Alvin J Siteman Cancer Center was named a NCI Designated Cancer Center
In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…
-
The Hutchinson Cancer Research Center played key role in largest-ever prostate-cancer prevention study
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
-
The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
-
The Seattle Cancer Care Alliance opened its doors
On Jan. 19, 2001, the Seattle Cancer Care Alliance outpatient clinic opened, the final phase in a more…
-
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
